U.S. Markets closed

Benefitfocus (BNFT) Shares March Higher, Can It Continue?

Style Box ETF report for JHMM

Benefitfocus, Inc. BNFT has been on the move lately as the stock has risen by 37.3% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?

While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on BNFT is moving in the right direction. In fact, the stock currently has a Zacks Rank #2 (Buy), suggesting that the recent run could certainly continue for this in-focus company.  You can see the complete list of today’s Zacks #1 Rank stocks here.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Benefitfocus, Inc. (BNFT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research